Detalles de la búsqueda
1.
Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials.
Br J Dermatol
; 188(2): 218-227, 2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36763878
2.
Lebrikizumab monotherapy impacts on quality of life scores through improved itch and sleep interference in two Phase 3 trials.
J Dermatolog Treat
; 35(1): 2329240, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38679419
3.
Early Onset of Clinical Improvement with Ixekizumab in a Randomized, Open-label Study of Patients with Moderate-to-severe Plaque Psoriasis.
J Clin Aesthet Dermatol
; 11(5): 33-37, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29785237
4.
Patient and Provider Characteristics Associated With Optimal Post-Fracture Osteoporosis Management.
Am J Med Qual
; 32(6): 644-654, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28693331
5.
Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials.
JAMA Dermatol
; 152(6): 661-9, 2016 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26953848
Resultados
1 -
5
de 5
1
Próxima >
>>